Zurueck zur Suche

Reporte zur Charge F3NL3

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MD 1 MO 1 FL 1 TX 1 NY 1

VAERS 1833305

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge F3NL3

schwer
Staat
MD
Alter
11,0
Geschlecht
M
Eingang
01.11.2021
Impfdatum
01.11.2021
Beginn
01.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose normal Fall Syncope

Symptomtext

This nurse gave pt shots when she turned to throw needles away in sharps container. Pt fainted and fell off examine table to the ground. Pt was rushed to by this nurse, Dr. , and pt mom. Pt was given a cool cloth for forehead, ice pack for head, vs taken, and blood sugar taken. All vs within normal ranges. Pt given time to rest and monitored by physician.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
none
Allergien
no
Vorherige Impfungen
-

VAERS 1801798

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge f3nl3

schwer
Staat
MO
Alter
13,0
Geschlecht
M
Eingang
20.10.2021
Impfdatum
20.10.2021
Beginn
20.10.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Hypotonia Loss of consciousness Memory impairment Pallor Seizure

Symptomtext

13 y/o patient and mother presented to pharmacy for a Boostrix shot and a Menveo shot. Immunization selection tool was used and patients shots were input and sold. Needle was attached to prefilled Boostrix syringe. (MENVEO shot was never given). Pulled patient into vaccination room and asked mother to stay for shot, she insisted and gave permission to give it and she went to car. Boostrix shot was given IM into left deltoid and bandaid was placed on arm. Patient went limp and I thought he passed out. Patient then began seizing and I helped lower him to the floor and protected his head and called out for help. I had someone call 911. Patient came to a few seconds later and knew his first name, but not his last. He was unaware of what happened. I monitored pulse and temperature while waiting for EMS to arrive. Both were normal except patient was pale. Paramedics arrived and checked him out and he seemed okay but they took him to check him out. No treatment was given and 911 suggested not to give any food or water.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Not aware of any
Aktuelle Erkrankungen
unknown
Vorgeschichte
none known
Andere Medikamente
unknown
Allergien
blueberries
Vorherige Impfungen
-

VAERS 1633764

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge F3NL3

schwer
Staat
FL
Alter
23,0
Geschlecht
M
Eingang
25.08.2021
Impfdatum
25.08.2021
Beginn
25.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Loss of consciousness Vomiting

Symptomtext

Patient went unconscious after receiving all vaccines. Patient regained consciousness after about 15-30 seconds and remained light headed and dizzy. The patient then began vomiting. EMS was called and the patient was escorted to the hospital via EMS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 1761312

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge F3NL3

mild
Staat
TX
Alter
52,0
Geschlecht
F
Eingang
05.10.2021
Impfdatum
25.08.2021
Beginn
25.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

The patient was given 3 vaccines during a scheduled flu clinic. She received flu (left upper deltoid), shingles (right deltoid), and tdap (right upper deltoid) vaccines. Later that evening she developed a widespread rash covering most part of her body. She made an appointment with her MD who treated her accordingly.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1489510

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge F3NL3

mild
Staat
NY
Alter
11,0
Geschlecht
M
Eingang
21.07.2021
Impfdatum
14.07.2021
Beginn
15.07.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Injection site erythema Injection site oedema Injection site pruritus Injection site urticaria Oedema Pruritus

Symptomtext

hives/ on the right deltoid at the injection site; mild edema/ on the right deltoid at the injection site; mild erythema/ on the right deltoid at the injection site; itching/ on the right deltoid at the injection site; This case was reported by a physician via call center representative and described the occurrence of injection site hives in a 11-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number F3NL3, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 14th July 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 15th July 2021, 1 days after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced injection site hives, injection site edema, injection site erythema and injection site itching. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the injection site hives, injection site edema, injection site erythema and injection site itching were not recovered/not resolved. It was unknown if the reporter considered the injection site hives, injection site edema, injection site erythema and injection site itching to be related to Boostrix and Boostrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The patient received Boostrix on 14th July 2021, in the right deltoid. HCP (healthcare professional ) stated that, the next day on 15th July 2021, the patient began to experiencing itching, mild erythema, mild edema, and hives on the right deltoid at the injection site. The patient had received Benadryl for side effects. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Boostrix Pre-Filled Syringe Device
Allergien
-
Vorherige Impfungen
-